Wave Life Sciences Ltd. (WVE) Announces Fiscal Q4 and Full-Year 2025 Earnings [Yahoo! Finance]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Yahoo! Finance
Wave Life Sciences Ltd. (NASDAQ: WVE ) is one of the best hot stocks under $20 to buy . Wave Life Sciences Ltd. (NASDAQ:WVE) released its fiscal Q4 and full-year 2025 earnings on February 26, reporting that it is on track for INLIGHT clinical data update in 1Q 2026, with fat loss similar to GLP-1 observed at three months and anticipated to continue over time and with higher doses of WVE-007 while preserving muscle mass. The company further stated that planning is underway for the initiation of Phase 2a multidose portion of WVE-007 INLIGHT clinical trial for obesity in individuals with higher BMI and comorbidities in 1H 2026, along with additional trials of WVE-007 as an incretin add-on and as post-incretin maintenance in 2026. Meta Stock: $750 Target Stays as Analysts Expect AI Gaps to Close Wave Life Sciences Ltd. (NASDAQ:WVE) reported cash and cash equivalents of $602.1 million as of December 31, 2025, compared to $302.1 million as of December 31, 2024, with the growth in cash
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International ConferenceGlobeNewswire
- WAVE Life Sciences (WVE) had its "buy" rating reaffirmed by HC Wainwright. They now have a $30.00 price target on the stock.MarketBeat
- Wave Life Sciences Teases Near-Term Obesity and RNA Editing Data as INLIGHT Readouts Near [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Ltd. (WVE): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
WVE
Earnings
- 2/26/26 - Miss
WVE
Sec Filings
- 2/27/26 - Form 4
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- WVE's page on the SEC website